Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jade Ghosn

Showing results (151-160 of 267) with videos related to

Pageof 27
Sort By:
The Journal of Infectious Diseases|June 24, 2021
HIV-1 RNA Kinetics in Blood Plasma and in Seminal Plasma of Men Starting a Dolutegravir-Based Triple-Combination Regimen at the Time of Primary HIV-1 InfectionJade Ghosn, Lambert Assoumou, Caroline Lascoux-Combe, et al.
Journal of the International AIDS Society|November 14, 2014
CD4+ cell count recovery in naïve patients initiating cART, who achieved and maintained plasma HIV-RNA suppressionDominique Costagliola, Jean-Marc Lacombe, Jade Ghosn, et al.
HIV Medicine|June 26, 2025
Rapid start with bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) as initial treatment in people with human immunodeficiency virus-1 (HIV-1): A systematic literature review of clinical and patient-reported outcomesJade Ghosn, Jeremy Chow, Monica Gandhi, et al.
Retrovirology|February 23, 2017
Spatiotemporal dynamics of HIV-1 transmission in France (1999-2014) and impact of targeted prevention strategiesAntoine Chaillon, Asma Essat, Pierre Frange, et al.
The Journal of Antimicrobial Chemotherapy|November 6, 2023
Proportion of APOBEC3-induced defective HIV DNA after 1 year of dolutegravir + lamivudine simplification in the ANRS 167 LAMIDOL trialFella Mazouz, Mélanie Bertine, Romain Coppée, et al.
AIDS (London, England)|April 20, 2004
Evidence of genotypic resistance diversity of archived and circulating viral strains in blood and semen of pre-treated HIV-infected menJade Ghosn, Jean-Paul Viard, Christine Katlama, et al.
Antiviral Therapy|July 26, 2005
Muscle and liver lactate metabolism in HAART-treated and naive HIV-infected patients: the MITOVIR studyJade Ghosn, Marguerite Guiguet, Claude Jardel, et al.
Journal of Medical Virology|June 8, 2023
Genomic diversity of mpox virus in Paris area (France) during the 2022 outbreakGéraldine Piorkowski, Jade Ghosn, Romain Coppée, et al.
Journal of Medical Virology|October 2, 2012
Switching to darunavir/ritonavir 800/100 mg once-daily containing regimen maintains virological control in fully suppressed pre-treated patients infected with HIV-1Jade Ghosn, Laurence Slama, Aziza Chermak, et al.
Plos Medicine|November 30, 2021
Obstetrical outcomes and maternal morbidities associated with COVID-19 in pregnant women in France: A national retrospective cohort studySylvie Epelboin, Julie Labrosse, Jacques De Mouzon, et al.
Pageof 27

Showing results (151-160 of 267) with videos related to

Sort By:
Pageof 27
The Journal of Infectious Diseases|June 24, 2021
HIV-1 RNA Kinetics in Blood Plasma and in Seminal Plasma of Men Starting a Dolutegravir-Based Triple-Combination Regimen at the Time of Primary HIV-1 InfectionJade Ghosn, Lambert Assoumou, Caroline Lascoux-Combe, et al.
Journal of the International AIDS Society|November 14, 2014
CD4+ cell count recovery in naïve patients initiating cART, who achieved and maintained plasma HIV-RNA suppressionDominique Costagliola, Jean-Marc Lacombe, Jade Ghosn, et al.
HIV Medicine|June 26, 2025
Rapid start with bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) as initial treatment in people with human immunodeficiency virus-1 (HIV-1): A systematic literature review of clinical and patient-reported outcomesJade Ghosn, Jeremy Chow, Monica Gandhi, et al.
Retrovirology|February 23, 2017
Spatiotemporal dynamics of HIV-1 transmission in France (1999-2014) and impact of targeted prevention strategiesAntoine Chaillon, Asma Essat, Pierre Frange, et al.
The Journal of Antimicrobial Chemotherapy|November 6, 2023
Proportion of APOBEC3-induced defective HIV DNA after 1 year of dolutegravir + lamivudine simplification in the ANRS 167 LAMIDOL trialFella Mazouz, Mélanie Bertine, Romain Coppée, et al.
AIDS (London, England)|April 20, 2004
Evidence of genotypic resistance diversity of archived and circulating viral strains in blood and semen of pre-treated HIV-infected menJade Ghosn, Jean-Paul Viard, Christine Katlama, et al.
Antiviral Therapy|July 26, 2005
Muscle and liver lactate metabolism in HAART-treated and naive HIV-infected patients: the MITOVIR studyJade Ghosn, Marguerite Guiguet, Claude Jardel, et al.
Journal of Medical Virology|June 8, 2023
Genomic diversity of mpox virus in Paris area (France) during the 2022 outbreakGéraldine Piorkowski, Jade Ghosn, Romain Coppée, et al.
Journal of Medical Virology|October 2, 2012
Switching to darunavir/ritonavir 800/100 mg once-daily containing regimen maintains virological control in fully suppressed pre-treated patients infected with HIV-1Jade Ghosn, Laurence Slama, Aziza Chermak, et al.
Plos Medicine|November 30, 2021
Obstetrical outcomes and maternal morbidities associated with COVID-19 in pregnant women in France: A national retrospective cohort studySylvie Epelboin, Julie Labrosse, Jacques De Mouzon, et al.
Pageof 27